<VariationArchive VariationID="1806262" VariationName="NM_170606.3(KMT2C):c.10724_10725dup (p.Ile3576fs)" VariationType="Duplication" Accession="VCV001806262" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2022-12-24" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1863272" VariationID="1806262">
      <GeneList>
        <Gene Symbol="KMT2C" FullName="lysine methyltransferase 2C" GeneID="58508" HGNC_ID="HGNC:13726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q36.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="152134925" stop="152436003" display_start="152134925" display_stop="152436003" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="151832009" stop="152133089" display_start="151832009" display_stop="152133089" Strand="-" />
          </Location>
          <OMIM>606833</OMIM>
          <Haploinsufficiency last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2C">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2C">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_170606.3(KMT2C):c.10724_10725dup (p.Ile3576fs)</Name>
      <CanonicalSPDI>NC_000007.14:152162851:AG:AGAG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q36.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="152162851" stop="152162852" display_start="152162851" display_stop="152162852" variantLength="2" positionVCF="152162851" referenceAlleleVCF="T" alternateAlleleVCF="TAG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="151859936" stop="151859937" display_start="151859936" display_stop="151859937" variantLength="2" positionVCF="151859936" referenceAlleleVCF="T" alternateAlleleVCF="TAG" />
      </Location>
      <ProteinChange>I3576fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.151859937_151859938dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.151859937_151859938dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.152162852_152162853dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.152162852_152162853dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033948.1" sequenceAccession="NG_033948" sequenceVersion="1" change="g.278153_278154dup">
            <Expression>NG_033948.1:g.278153_278154dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_170606.3" sequenceAccession="NM_170606" sequenceVersion="3" change="c.10724_10725dup" MANESelect="true">
            <Expression>NM_170606.3:c.10724_10725dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_733751.2" sequenceAccession="NP_733751" sequenceVersion="2" change="p.Ile3576fs">
            <Expression>NP_733751.2:p.Ile3576fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_170606.3" sequenceAccession="NM_170606" sequenceVersion="3" change="c.10724_10725dupCT" MANESelect="true">
            <Expression>NM_170606.3:c.10724_10725dupCT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_170606.3(KMT2C):c.10724_10725dup (p.Ile3576fs) AND Kleefstra syndrome 2" Accession="RCV002470546" Version="2">
        <ClassifiedConditionList TraitSetID="39647">
          <ClassifiedCondition DB="MedGen" ID="C4540395">Kleefstra syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="39647" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38345" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kleefstra syndrome 2</ElementValue>
                <XRef ID="MONDO:0054701" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KLEFS2</ElementValue>
                <XRef Type="MIM" ID="617768" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18382" />
                <XRef ID="18382" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C4540395" DB="MedGen" />
              <XRef ID="MONDO:0054701" DB="MONDO" />
              <XRef Type="MIM" ID="617768" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5415315" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_170606_2_KMT2C_c_10724_10725dupCT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002768703" DateUpdated="2024-07-23" DateCreated="2022-12-24" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Kleefstra syndrome 2 (MIM#617768). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. More than 10 other NMD-predicted variants have previously been reported as pathogenic in patients with Kleefstra syndrome (ClinVar, DECIPHER). (SP) 0802 - This variant has moderate previous evidence of pathogenicity in an unrelated individual. This variant has been reported as pathogenic, heterozygous and de novo (unconfirmed parentage) in an individual in DECIPHER with limited phenotypic information provided. (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed, by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2C" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_2405</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_170606.2:c.10724_10725dupCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617768" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5415315" TraitType="Disease" MappingType="XRef" MappingValue="617768" MappingRef="OMIM">
        <MedGen CUI="C4540395" Name="Kleefstra syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

